Abstract |
In 85 patients with psoriasis vulgaris the efficacy and tolerance of domoprednate and betamethasone valerate were studied in a double-blind, randomized trial lasting 4 weeks. Complete or satisfactory remission was obtained in 36% in the domoprednate group and in 53% in the betamethasone group. This difference is not statistically significant (p greater than 0.10). 3 patients on each treatment experienced some local irritation. No laboratory abnormalities were found during the study.
|
Authors | J V Christiansen, E Foged, P Holm, A S Jørgensen, F Reymann |
Journal | Dermatologica
(Dermatologica)
Vol. 170
Issue 4
Pg. 195-8
( 1985)
ISSN: 0011-9075 [Print] Switzerland |
PMID | 3888709
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Ointments
- Pregnadienes
- domoprednate
- Betamethasone
- Betamethasone Valerate
|
Topics |
- Adolescent
- Adult
- Aged
- Betamethasone
(analogs & derivatives)
- Betamethasone Valerate
(administration & dosage, adverse effects)
- Clinical Trials as Topic
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Ointments
- Pregnadienes
(administration & dosage, adverse effects)
- Psoriasis
(drug therapy)
- Random Allocation
|